HM
Howard Marks (Oaktree Capital) disclosed decreased in JAZZ PHARMACEUTICALS PLC
Howard Marks (Oaktree Capital) filed a 13F change in JAZZ PHARMACEUTICALS PLC (472145AH4) on 2026-05-20, covering period end 2026-03-31.
Action
Decreased
Capital
$12,062,672 reported value
Institutional 13F Signals1 evidence source
Why it matters
This signal is anchored to the SEC filing date while retaining the underlying 13F period end.